(ADAP) Adaptimmune Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Adaptimmune Therapeutics | (ADAP) share price targets
Complete technical analysis of Adaptimmune Therapeutics (ADAP) by charts plus indicators, forecast predictions and share price targets for Adaptimmune Therapeutics (ADAP)
Adaptimmune Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-11-01 View latest technical analysis
10 day averaged volume of Adaptimmune Therapeutics is 1278290
| Date | Daily Closing Price | Open | High | Low | Volume |
| 01 Fri Nov 2024 | 0.80 | 0.73 | 0.82 | 0.73 | 0.875 times |
| 31 Thu Oct 2024 | 0.73 | 0.71 | 0.75 | 0.70 | 0.972 times |
| 30 Wed Oct 2024 | 0.70 | 0.70 | 0.72 | 0.67 | 2.188 times |
| 29 Tue Oct 2024 | 0.70 | 0.74 | 0.75 | 0.70 | 0.643 times |
| 28 Mon Oct 2024 | 0.74 | 0.74 | 0.77 | 0.73 | 1.049 times |
| 25 Fri Oct 2024 | 0.74 | 0.75 | 0.79 | 0.72 | 1.331 times |
| 24 Thu Oct 2024 | 0.75 | 0.78 | 0.78 | 0.74 | 0.924 times |
| 23 Wed Oct 2024 | 0.78 | 0.83 | 0.85 | 0.78 | 0.577 times |
| 22 Tue Oct 2024 | 0.81 | 0.82 | 0.83 | 0.80 | 0.975 times |
| 21 Mon Oct 2024 | 0.82 | 0.84 | 0.85 | 0.82 | 0.753 times |
Share price targets for Adaptimmune Therapeutics (ADAP)
| Target Type | Value |
| Downside Target | 0.67 |
| Downside Target | 0.72 |
| Upside Target | 0.82 |
| Upside Target | 0.85 |
| Upside Target | 0.90 |
| Upside Target | 0.94 |
| Upside Target | 0.96 |
| Upside Target | 0.98 |
| Upside Target | 1.00 |
| Upside Target | 1.32 |
| Upside Target | 1.36 |
| Upside Target | 1.48 |
Intraday share price targets for Adaptimmune Therapeutics (ADAP)
| Target Type | Value |
| Downside Intraday Target | 0.71 |
| Downside Intraday Target | 0.61 |
| Upside Intraday Target | 0.86 |
| Upside Intraday Target | 0.91 |
| Downside Intraday Target | 0.76 |
Weekly technical analysis of Adaptimmune Therapeutics (ADAP)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 01 Fri Nov 2024 | 0.80 | 0.74 | 0.82 | 0.67 | 1.256 times |
| 25 Fri Oct 2024 | 0.74 | 0.84 | 0.85 | 0.72 | 0.919 times |
| 18 Fri Oct 2024 | 0.84 | 0.88 | 0.90 | 0.83 | 1.644 times |
| 11 Fri Oct 2024 | 0.87 | 0.94 | 0.96 | 0.86 | 0.766 times |
| 04 Fri Oct 2024 | 0.95 | 0.98 | 1.00 | 0.86 | 0.748 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Adaptimmune Therapeutics (ADAP)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 01 Fri Nov 2024 | 0.80 | 0.73 | 0.82 | 0.73 | 0.042 times |
| 31 Thu Oct 2024 | 0.73 | 0.94 | 0.96 | 0.67 | 1.299 times |
| 30 Mon Sep 2024 | 0.95 | 1.24 | 1.32 | 0.87 | 0.403 times |
| 30 Fri Aug 2024 | 1.27 | 1.33 | 1.36 | 0.94 | 1.214 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Adaptimmune Therapeutics (ADAP)
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Adaptimmune Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Adaptimmune Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Adaptimmune Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Adaptimmune Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.75 and Adaptimmune Therapeutics (ADAP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Adaptimmune Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Adaptimmune Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Adaptimmune Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Adaptimmune Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.75 and Adaptimmune Therapeutics (ADAP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.